The founder of AHT company, as a medical doctor, was closely in relation
with people and society health since 1999. On this basis and regarding the
variations that happened in people lifestyle, he felt the need of society to
supply new generation and high quality knowledge base supplement and
beauty care products to support and increase the level of health and
youthfulness of the society, which made him to enter the health products
formulation, manufacturing and supply industry.
Since 2010 the founders of the company had been researching the
development of the technical knowledge to produce some Nootropic peptide
base supplements. Upon accomplishment, they established their first
company in 2015.
Since 2015 they could expand their first company products to more than 15
chemical and natural medicine and supplements in different fields such as
nervous system, heart, and blood circulation.
– Along that they not only achieved enough experience and relation with
international manufacturer and distribution companies but also their
marketing team received proper feedbacks about what line of products are
necessary in market for increasing society health and youthfulness.
They established AHT LLC. company in that regard with a strong
background in pharma and supplement formulation, production and
distribution.
AHT area of activity is designed for providing international wholesaling,
and manufacturing of new generation of health, beauty care, and food
supplements.
AHT R&D team is active in improvement of their pipeline basket
(wholesaling and contract manufacturing) and in technology transfer
Our investments flow mainly in the following areas:
R&D for new generation health and beauty care products by focusing on peptide
base products
Research on providing and wholesaling of the novel high-quality supplements
and cosmetics
Establishment and expansion of our facilities in new warehouse.
Serox ; cooperation in Germany and Turkey with regards to knowledge exchange
and procurement of medications and material
Bazaargain ; Germany, commercial consultation